Back to search
FDAFDA · Food and drugs·Recall number D-1331-2022

FentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL (10 mcg per mL) IV bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-327-01.

Published August 17, 2022 · Recall initiated: July 25, 2022

Summary

FDA records drug Class II recall D-1331-2022, published August 17, 2022 and initiated July 25, 2022. Recalling firm: SterRx, LLC; Status: Terminated; Reported quantity: 720 bags; Lot: Lot #: CHI, Exp. Date Dec 22, 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SterRx, LLC
Distributor
Nationwide within the United States
Lot
Lot #: CHI, Exp. Date Dec 22, 2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL (10 mcg per mL) IV bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-327-01. recalled?

Yes. FDA published recall D-1331-2022 on August 17, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter